The value of screening for Down's syndrome in a socioeconomically deprived area with a high ethnic population

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 105, Issue 8, 1998, Pages 855-859

  Ford, C ^a   Moore, A J ^a   Jordan, P A ^a   Bartlett, W A ^a   Wyldes, M P ^a   Jones, A F ^a   MacKenne, W E ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMNIOCENTESIS; ARTICLE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DOWN SYNDROME; ETHNIC DIFFERENCE; FEMALE; FETUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASS SCREENING; MULTICENTER STUDY; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL;

AMNIOCENTESIS; ASIA; COSTS AND COST ANALYSIS; DOWN SYNDROME; ENGLAND; FEMALE; GESTATIONAL AGE; HUMANS; MASS SCREENING; MEDICAL AUDIT; PATIENT ACCEPTANCE OF HEALTH CARE; POVERTY AREAS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 0031670098     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1998.tb10229.x     Document Type: Article

References (12)

1. Royal College of Obstetricians and Gynaecologists. Report of the RCOG Working Party on biochemical markers and the detection of Down's syndrome. London: RCOG Press, 1993.
2. Wald NJ, Kennard A, Densem JW, Cuckle HS, Chard T, Butler L. Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. BMJ 1992; 305: 391–394.
3. Fletcher J, Hicks NR, Kay JDS, Boyd PA. Using decision analysis to compare policies for antenatal screening for Down's syndrome. BMJ 1995; 311: 351–356.
4. Torgerson DJ, Spencer A. Marginal costs and benefits. BMJ 1996. 312 35–36.
5. Gilbert L, Nicholl J, Alex S, Smethurst I, Mapeer A, Andrews A et al. Ethnic differences in the outcome of serum screening for Down's syndrome. BMJ 1996; 312:94–95.
6. Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Cannick JA et al. Prenatal screening for Down's syndrome with use of maternal serum markers. N Fzgl J Med 1992; 327: 588–593.
7. Saridogan E, Djahanbakhch O, Naftalin AA. Screening for Down's syndrome: experience in an inner city health district. Br J Obstet Gynaecol 1996; 103: 1205–1211.
8. Tabor A, Masden M, Obell GB, Philip J, Bang J, Norgard- Pederson B. A Randomised controlled trial of genetic amniocentesis in 4606 low risk women. Lancet 1986; 1: 1287–1292.
9. Holloway PJ, Bulusu S. Ethnic differences in outcome of serum screening for Down's syndrome. For appreciable ethnic differences in false positive rates, use different cut off points. BMJ 1996; 312: 1041.
10. Spencer K. Ethnic differences in outcome of serum screening for Down's syndrome. Median values and maternal weight specific to the ethnic group should be used. BMJ 1936; 312: 1041.
11. Ford C, Moore A, Bartlett WA, Jones AF. Ethnic differences in outcome of serum screening for Down's syndrome. Differences in median values may account for differences in false positive rates. BMJ 1996; 312: 1040–1041.
12. Torgerson D. The impact of maternal age on the cost effectiveness of Down's syndrome screening. Br J Obstri Gynaecol 1996; 103: 581–583.